Search Results 1131-1140 of 13934 for Assay
... assay method) and laboratory reference ranges. Additional inclusion criteria are defined in the study protocol. Exclusion Criteria: * Anticipated need for ...
Documentation of an NRAS mutation (tumor tissue or blood) prior to first dose of study drug(s) as determined locally with an analytically validated assay in a ...
hormone receptors (estrogen receptor [ER] or progesterone receptor [PR]) by IHC. ER and PR assays are considered positive if there are > 1% positive tumor ...
GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...
Subject has MM positive for t(11;14) as determined by an analytically validated fluorescent in situ hybridization (FISH) assay per centralized laboratory ...
Has laboratory-confirmed (within 14 days prior to enrollment) SARS-CoV-2 infection as determined by PCR or other commercial or public health assay in any ...
... assay consistent with local standards. Documentation of HER2-negative tumor based on local testing of the most recent tumor biopsy, as per most recent ...
Laboratory techniques performed and discussed are screening tests and specific assays for clotting abnormalities. There is an emphasis on the correlation of ...
The fecal immunochemical test (FIT) can help find cancer early in the colon or rectum. You take the test at home. There's no preparation needed.
Positive anti-mitochondrial antibody (AMA) titers (>1/40 on immunofluorescence or M2 positive by enzyme linked immunosorbent assay [ELISA]) or positive PBC- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.